Vitamin D and Prostate Cancer: A Prediagnostic Study with Stored Sera

Cancer Epidemiology Biomarkers and Prevention

Volumn 2, Issue 5, 1993, Pages 467-472

  Corder, Elizabeth H ^a   Guess, Harry A ^c   Hulka, Barbara S ^c   Friedman, Gary D ^d   Sadler, Marianne ^d   Vollmer, Robin T ^b   Lobaugh, Bruce ^a   Drezner, Marc K ^a   Vogelman, Joseph H ^e   Orentreich, Norman ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d KAISER PERMANENTE   (United States)

^e Orentreich Foundation for the Advancement of Science Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CALCIUM; HYDROXYCOLECALCIFEROL; PHOSPHATE;

ADULT; AGE; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CAUCASIAN; CAUSE OF DEATH; FORECASTING; HOSPITALIZATION; HUMAN; MALE; METABOLISM; NEGRO; PATHOLOGY; PROSTATE TUMOR; RISK FACTOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CALCIFEDIOL; CALCITRIOL; CALCIUM; CASE-CONTROL STUDIES; CAUCASOID RACE; CAUSE OF DEATH; FORECASTING; HOSPITALIZATION; HUMAN; HYDROXYCHOLECALCIFEROLS; MALE; MIDDLE AGE; NEGROID RACE; PHOSPHATES; PROSTATIC NEOPLASMS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027664955     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ries, L. A. G., Hankey, B. F., Miller, B. A., Hartman, A. M., and Edwards, B. K. Cancer Statistics Review 1973-88. Bethesda, MD: National Cancer Institute, NIH Pub. No. 91-2789, 1991.
2. American Cancer Society. Cancer Facts and Figures. New York: American Cancer Society, 1992.
3. Manolagas, S. C. Vitamin D and its relevance to cancer. Anticancer Res., 7: 625–638, 1987.
4. Reichel, H., Koeffler, H. P., and Norman A. W. The role of the vitamin D endocrine System in health and disease. N. Engl. J. Med., 320: 980–991, 1989.
5. Binderup, L., and Bramm, E. Effectsofa novel vitamin DanalogueMC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem. Pharmacol., 37: 889–895, 1988.
6. Colston, K., Berger, U., and Coombes, R. C. Possible role for vitamin D in Controlling breast cancer cell proliferation. Lancet, i: 188–191, 1989.
7. Schwartz, G. G., and Hulka, B. S. Is vitamin D a risk factor for prostate cancer? (Hypothesis). Anticancer Res., 10: 1307–1312, 1990.
8. Holick, M. F. Vitamin D: biosynthesis, metabolism, and mode of action. In: L. Degroot (ed.), Endocrinology, pp. 902–923. Philadelphia: W. B. Saunders, 1989.
9. Reichel, H., Koeffler, H. P., and Norman, A. W. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med., 320: 980–991, 1989.
10. Miller, G. J., Stapleton, G. E., Ferrara, J. A., Lucia, M. S., Pfister, S., Hedlund, T. E., and Upadhya, P. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1,25-dihydroxyvitamin D3. Cancer Res., 52: 515–520, 1992.
11. Collen, M. F., and Davis, L. F. The multitest laboratory in health care. J. Occup. Med., 11: 355–360, 1969.
12. Hiatt, R., and Friedman, G. D. The frequency of kidney and urinary tract disease in a defined population. Kidney International 22: 63–68, 1982.
13. Friedman, G. D., Blaner, W. S., Goodman, D. S., Vogelman, J. H., Brind, J. L., Hoover, R., Fireman, B. H., and Orentreich, N. Serum retinol and retinol- binding protein levels do not predict subsequent lung cancer. Am. J. Epidemiol., 723: 781–789, 1986.
14. Friedman, G. D., and Ury, H. K. Initial screening for carcinogenicity of commonly used drugs. J. Natl. Cancer Inst., 39: 861–870, 1980.
15. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research, Vol. 2, p. 297. Lyon, France: International Agency for Research on Cancer, 1980.
16. Gleason, D. F. Classification of prostatic carcinomas. Cancer Chemother. Rep., 50: 125–128, 1966.
17. Arellano, M. G., Petersen, G. R., Petitti, D. B., and Smith, R. E. The California automated mortality linkage system (CAMLIS). Am J. Public Health, 74: 1324–1330, 1984.
18. Bakerman, S. ABC's of Interpretive Laboratory Data 2nd Edition. Greenville, NC: Interpretive Laboratory Data, Inc., 1984.
19. Haddad, J. G., and Chyu, K. J. Competitive protein binding radioassay for 25-hydroxycholecalciferol. J. Clin. Endocrinol. Metab., 33: 992–996, 1971.
20. Belsey, R., DeLuca, H. F., and Potts, J. T. A rapid assay for 25-OH-vitamin D3 without preparative chromatography. J. Clin. Endocrinol. Metab., 38: 1046–1050, 1974.
21. Hollis, B. W. Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridgeextraction and purification procedure. Clin. Chem., 32: 2060–2063, 1986.
22. Kleinbaum, D. G., Küpper, L. L., and Morgenstern, H. Applications of modeling:conditional likelihood estimation. In: Epidemiologie Research, pp. 492–503. New York: Van Nostrand Reinhold, 1982.
23. Rao, C. R. Large sample theory and methods. In: Linear Statistical Inference and its Applications, pp. 350–351. New York: Wiley, 1965.
24. Cox, D. R., and Oakes, D. Analysis of Survival Data. London: Chapman and Hall, 1984.
25. Rothman, K. J. Modern Epidemiology, p. 250. Boston: Little, Brown and Co., 1986.
26. Garland, C. F., Comstock, G., Garland, F. C., Helsing, K., Shaw, E., and Gorham, E. Serum 25-hydroxyvitamin D and colon cancer: an eight-year prospective study. Lancet, ii: 1176–1178, 1989.
27. Garland, F. C., Garland, C. F., Gorham, E. D., and Young J. F. Geographie Variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev. Med., 19: 614–622, 1990.
28. Garland, F. C., White, M. R., Garland, C. F., Shaw, E., and Gorham, E. D. Occupational sunlight exposure and melanoma in the U.S. Nav. Arch. Environ. Health, 45: 261–267, 1990.
29. Gorham, E. D., Garland, F. C., and Garland, C. F. Sunlight and breast cancer incidence in the USSR. Int. J. Epidemiol., 79: 820–824, 1990.